Founded in January 2025, Ovo Labs is a biotech company that has emerged from the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen (Germany). The company develops novel therapeutics to improve the quality of human eggs. The active compounds are designed to help women remain fertile for longer and increase their chances of a successful pregnancy and in vitro fertilization (IVF). The launch of Ovo Labs gives new impetus to the fertility industry, an area in which technological innovation is becoming increasingly important.